Drugs / DHEA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02000375 | Mar 2013 → Feb 2016 | estrogen-receptor negative breast cancer, estrogen-receptor positive breast cancer, progesterone-receptor negative breast cancer, progesterone-receptor positive breast cancer | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02000375 ↗ |
| Route | Oral | “Daily oral administration of DHEA” NCT02000375 ↗ |